Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Identify Which Dividend Aristocrats ETF Has Highest Expense Ratio and discuss implications for costs and performance.
27,586 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Palantir's Alex Karp has reignited the AI debate, arguing that the market overstates near-term gains from frontier mo...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
Tilray Brands is set to report on July 28. This article breaks down whether should tilray brands stock be on your rad...
SoFi shareholders have faced a tough year, but a pair of upbeat bank results offers a new tailwind. This article brea...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
Kiavi announced a $350 million rated securitization of residential transition loans, marking its sixth rated deal and...
Ownwell secures a $50M Series B to broaden its AI-driven tax-appeals platform and roll out a nationwide packet for ho...
A 10% pullback is a normal market event, not a forecast of doom. Here’s what typically happens after a 10% drop and h...
A surge in fast-food automation is reshaping kitchens and wallets. Meet your robot cooks: AI fry arms move from pilot...
A rising productivity framework argues that some workplace tasks look busy but deliver little real value. This could ...